FDA Weighs In On Gilead's Crucial Pill - Forbes

The Quad is a once-a-day pill that aims to provide Gilead with a revenue stream that will last beyond the patent expiration of its key drug Viread and its current one-a-day, Atripla. The Quad also represents a real threat to Merck‘s Isentress.

HIV Drug Maker Gilead Sciences Scores Two Wins - Minyanville

The stock is up more than 6% since last Tuesday. In studies, Gilead showed that Quad worked at least as well as the company’s top-selling Atripla and was as safe as that drug. There are concerns about Quad’s effect on kidneys, which would ...

Gilead’s Quad Pill Raises Kidney Questions, FDA Says - Bloomberg

The stock has gained 23 percent in the past 12 months. Gilead’s three-drug pill Atripla, approved in 2006, is the top-selling AIDS medicine. The therapy mixes Gilead’s two-drug medicine Truvada, approved in 2004, with Bristol-Myers Squibb Co ...

Bernie Sanders Offers Plan To Cut Prescription Drug Prices - Huffington Post

During the hearing, Sanders discussed one such drug, Atripla, which he said costs roughly $25,000 a year for a single patient in the U.S., where it is marketed jointly by Gilead Sciences and Bristol-Myers Squibb. In countries that allow generic ...

Sen. Sanders' Common Sense on HIV Drugs Would Save Money and Lives - Huffington Post

He noted that one widely used HIV medication, Atripla, which combines three different drugs in one pill, costs $25,000 a year in the U.S. But an FDA-approved generic version of the same pill costs a mere $200 in the developing world. Sanders has offered a ...

A Step Closer to Quadrific Sales - Motley Fool

The extra kidney test might make it harder to get doctors to prescribe the Quad over Atripla, but the Quad has other advantages, including fewer abnormal dreams, less trouble sleeping, and less dizziness compared with Atripla. Kidney issues are ...

AIDS Advocates to Protest Gilead over Drug Pricing at May 10th Shareholders’ Meeting - StreetInsider.com

“The nation’s network of AIDS Drug Assistance Programs face desperate circumstances because of high prices for drugs like Gilead’s Atripla—and, soon, the ‘Quad.’ As a healthcare provider and advocacy group, AIDS Healthcare Foundation will ...

FDA Panel Endorses 'Quad' Pill for HIV - MedPage Today

If the FDA follows the advice of the panel and approves the quad drug, it would be the third single-pill, once-daily complete regimen for HIV, along with Atripla (efavirenz, emtricitabine, and tenofovir) and Complera (rilpivirine, emtricitabine ...

Sen. Bernie Sanders holds hearing to announce $3 billion AIDS drug prize - Raw Story

Raw Story spoke with Sanders’s chief counsel and legislative director Michael Behan, who cited the example of Atripla, a combination drug used to fight HIV. Currently, the drug retails at more than $25,000 per year per person. “Witnesses at ...

Four Ways to Make Medicine More Like Facebook - Forbes

Among the drugs launched since Facebook sprang out of Mark Zuckerberg’s dorm room: Atripla, the first once-a-day single-pill HIV drug cocktail; Merck’s vaccine against strains of human papilloma virus, which causes cervical cancer ...